SHARE

Belgium-Netherlands, France, Germany, InnoStars, Scandinavia, Spain, UK-Ireland, Accelerator, 2017

Twenty promising start-ups win €7k to develop business plans

4th August 2017

Winners will go on to compete for up to €30 000 in a pitch competitions

 

In the first elimination round of a competition that will yield prizes of up to €30 000, EIT Health InnoStars awarded 20 candidates grants of €7 000 to fund development of their business plans.
InnoStars received 78 eligible project proposals, from start-ups in Italy, Poland, Portugal, Greece and Hungary. After the first evaluation cut-off, undertaken by international experts, the TOP 20 shortlist has now been published, with winners from all five countries.

The 20 winners include a device that ensures high improvement in the early diagnosis of cardiovascular and chronic obstructive pulmonary diseases, and also interactive platforms/applications, like a therapy system that enables a unique, at-home, motor skills learning process for children who have suffered a stroke.

Assisted by experienced consultants, the 20 selected companies have until the end of September to submit their business plans. Based on a review of these plans, the top eight companies will be invited to compete with a final pitch in front of an international jury consisting of healthcare professionals, representatives of EIT Health core industrial partners and market experts. The three companies deemed to be the best in the pitch contest will be awarded up to €30 000.

For further enquiries please contact:

Anita Fuzi, anita.fuzi@eithealth.eu

AI tool for COVID-19 produces significant results

AI tool for COVID-19 produces significant results

EIT Health project aids personalised medicine

Find out more

EIT Health helps Tubulis secure €10.7M in funding

EIT Health helps Tubulis secure €10.7M in funding

Investor Network aids firm doing antibody work

Find out more

EIT Health-backed start-ups garner big investments

EIT Health-backed start-ups garner big investments

A million each for iLoF and Restorative Neurotechnologies

Find out more